Potential biological markers for the staging of tumor progression in oral mucosa: A multivariate analysis

被引:5
|
作者
Kannan, S
Chandran, GJ
Balaram, P
Chidambaram, S
Nair, MK
机构
[1] CONSULTING ACTUARY,THIRUVANANTHAPURAM,KERALA,INDIA
[2] REG CANC CTR,DIV RADIAT ONCOL,THIRUVANANTHAPURAM,KERALA,INDIA
来源
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS | 1996年 / 11卷 / 02期
关键词
tumor progression; biomarkers; biological staging; oral mucosa; oral cancer; cytoskeletal proteins; ras p21; EGFR; EGF;
D O I
10.1177/172460089601100202
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
A recent trend in cancer control programmes is the development of early detection strategies and chemoprevention of premalignant lesions. The present study evaluates the potential of selected markers in the biological staging of tumor progression in oral mucosa for better management of the disease. The expression patterns of various cytokeratin protein types such as 10/11, 13 & 16, 19, 18, 14 and pancytokeratin, involucrin, ras p21, epidermal growth factor (EGF) and its receptor (EGFR) were assessed immunohistochemically in various stages of tumor progression in oral mucosa. Statistical analyses such as the Kruskal-Wallis one-way ANOVA, Spearman's rank correlation and multiple regression analysis were carried out to see which proteins have a significant association with tumor progression in oral mucosa.-Statistical analysis showed that the expression patterns of cytokeratin types 10/11, 14 and 19, involucrin and epidermal growth factor were significantly correlated with tumor progression in oral mucosa in both univariate and multivariate analysis. Thus the biological stage of a lesion can be calculated from the multiple regression equation derived for these proteins, which could be more useful in assessing the stage of tumor progression in oral mucosa than histopathological grading.
引用
收藏
页码:67 / 76
页数:10
相关论文
共 50 条
  • [31] The tumor coagulome as a potential biological determinant of postsurgical recurrence of oral squamous cell carcinoma
    Saidak, Zuzana
    Galmiche, Antoine
    FRONTIERS IN ORAL HEALTH, 2025, 6
  • [32] Critical review and meta-analysis of biological variation estimates for tumor markers
    Marques-Garcia, Fernando
    Boned, Beatriz
    Gonzalez-Lao, Elisabet
    Braga, Federica
    Carobene, Anna
    Coskun, Abdurrahman
    Diaz-Garzon, Jorge
    Fernandez-Calle, Pilar
    Carmen Perich, Maria
    Simon, Margarida
    Jonker, Niels
    Aslan, Berna
    Bartlett, William Alexander
    Sandberg, Sverre
    Aarsand, Aasne K.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2022, 60 (04) : 494 - 504
  • [33] Concomitant analysis of salivary tumor markers - A new diagnostic tool for oral cancer
    Nagler, Rafael
    Bahar, Gideon
    Shpitzer, Thomas
    Feinmesser, Raphael
    CLINICAL CANCER RESEARCH, 2006, 12 (13) : 3979 - 3984
  • [34] Potential diagnostic markers and biological mechanism for osteoarthritis with obesity based on bioinformatics analysis
    Li, Qiu
    Tang, Xijie
    Li, Weihua
    PLOS ONE, 2023, 18 (12):
  • [35] Identification of novel tumor markers for oral squamous cell carcinoma using glycoproteomic analysis
    Chen, Yi-Ting
    Chong, Yi-Min
    Cheng, Chu-Wen
    Ho, Chung-Liang
    Tsai, Hung-Wen
    Kasten, Frederick H.
    Chen, Yu-Ling
    Chang, Chuan-Fa
    CLINICA CHIMICA ACTA, 2013, 420 : 45 - 53
  • [36] Prognostic Value of Cancer Stem Cell Markers in Potentially Malignant Disorders of Oral Mucosa: A Meta-analysis
    Saluja, Tajindra Singh
    Ali, Murtaza
    Mishra, Prabhaker
    Kumar, Vijay
    Singh, Satyendra Kumar
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2019, 28 (01) : 144 - 153
  • [37] Hematopoietic cytokines as tumor markers in gynecological malignancies. A multivariate analysis in epithelial ovarian cancer patients
    Lawicki, Slawomir
    Gacuta-Szumarska, Ewa
    Bedkowska, Grazyna Ewa
    Szmitkowski, Maciej
    GROWTH FACTORS, 2012, 30 (06) : 357 - 366
  • [38] Hematopoietic cytokines as tumor markers in gynecological malignancies: A multivariate analysis with ROC curve in endometrial cancer patients
    Lawicki, Slawomir
    Bedkowska, Grazyna Ewa
    Gacuta-Szumarska, Ewa
    Szmitkowski, Maciej
    GROWTH FACTORS, 2012, 30 (01) : 29 - 36
  • [39] THE VALUE OF HISTOLOGIC GRADING AND STAGING, RANDOM BIOPSIES, TUMOR AND BLADDER MUCOSA BLOOD-GROUP ANTIGENS, IN PREDICTING PROGRESSION OF SUPERFICIAL BLADDER-CANCER
    HULAND, H
    KLOPPEL, G
    OTTO, U
    DROESE, M
    EUROPEAN UROLOGY, 1984, 10 (01) : 28 - 31
  • [40] The Potential of Colonic Tumor Tissue Fusobacterium nucleatum to Predict Staging and Its Interplay with Oral Abundance in Colon Cancer Patients
    Pignatelli, Pamela
    Iezzi, Lorena
    Pennese, Martina
    Raimondi, Paolo
    Cichella, Anna
    Bondi, Danilo
    Grande, Rossella
    Cotellese, Roberto
    Di Bartolomeo, Nicola
    Innocenti, Paolo
    Piattelli, Adriano
    Curia, Maria Cristina
    CANCERS, 2021, 13 (05) : 1 - 19